Resources

Aggressive blood pressure control may be the most important factor in preventing adverse outcomes in patients with type 2 diabetes.

Quality of care, not availability of care, appears to be the key to preventing hospitalization among patients with diabetes, Dr. James Bailey said at the southern regional meeting of the American Federation for Medical Research.

Enalapril treatment resulted in an absolute risk reduction of 22.4 percentage points for the development of clinical albuminuria over five years.

Increases in blood pressure in young adulthood precede the development of type 2 diabetes in middle age.

Could this be in store for the U.S. and other countries?

After 16 weeks of treatment, mean reductions of HbA1c were -1.6% for the repaglinide group and -1.0% for the nateglinide group.

Rofecoxib significantly increased systolic blood pressure, while celecoxib (Celebrex) and naproxen did not.

Patients form their own support group. Over time, patients develop relationships with others in a way that is very difficult with the 15-minute drop-in visit a couple of times a year.

People who eat breakfast are up to 50% less likely to be obese and diabetic than those who usually do not.

American children whose genetic roots strongly reach back to Africa are less sensitive to insulin-a factor important in the development of type 2 diabetes-than those whose ancestors hailed heavily from Europe.